Innovent Biologics Technology Limited (shanghai R&d Center)

This study tests a new eye injection called IBI302 for people with diabetic macular edema, a condition that causes vision loss due to diabetes. About 150 adults aged 18-80 with type 1 or 2 diabetes and swelling in the center of the retina will receive either IBI302 or an active c…

This early-stage study is testing a new drug called IBI3032 in 79 adults who are overweight or have obesity. The main goal is to check if the drug is safe and how the body processes it over a 4-week treatment period. Participants receive either the drug or a placebo, and research…